Investing Profile

Nancy Hong

InvestorVC

Managing Director at RiverVest Venture Partners

rivervest.com/team-member/nan...San Diego, California

‌

‌

‌

Your Intro Paths to Nancy Hong

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

Find Nancy Hong on

cb

Current Investing Position

RiverVest Managing Director

Investment Range

$100K - $10.0M

Sweet Spot

$1M

Investments On Record

8

Current Fund Size

$184.4M

Nancy Hong is on these Sector & Stage Rankings

Pharmaceuticals (Seed)BioTech (Seed)BioTech (Series A)Pharmaceuticals (Series A)Health IT (Series A)Los Angeles / Southern California Enterprise (Series A)Health & Hospital Services (Series A)Health IT (Seed)Health & Hospital Services (Seed)Enterprise (Seed)

Nancy Hong's Investments On Record (5)

Company	StageDateRound Size	Total Raised
Bluejay Therapeutics	Series CMay 2024$180M Series BAug 2022$41M	$220M
Co-investors: Daniel Estes (Frazier Healthcare Partners)
Biolinq	Series BNov 2021$100M	$110M
Co-investors: Katie Ellias (T1D Fund)
Scout Bio	Series BOct 2021$33M Series BMar 2019$20M	$53M
Co-investors: Cindy Cole (Digitalis Ventures)
SeQure Dx	Series AApr 2021$18M	$18M
Xilio Therapeutics	Series CFeb 2021$95M Series BMar 2020$100M	$330M
Co-investors: Peter Dudek (MRL Ventures Fund), Mike Ross (SV Health Investors), Jayson Punwani (Abingworth), Andrew Hack (Bain Capital Life Sciences), Jack Kenney (SV Health Investors)

Investors who invest with Nancy Hong

Andrew Kleiboeker